Wrinkles

... DeHavilland: political news feed, public and current affairs, news information service:dehavilland               Wed 15 Feb-06 14:01      MAIN MENU     News Headlines   DeHavilland   Employment   Contact  PublicAffairsBriefing™ The UK's leading political issue-tracking service for corporate & public affairs professionals. Request a Trial  National News Botox could be used to fight cancer15/02/2006 Botox could be used alongside chemotherapy and radiation to fight cancer, new research has suggested.

The cosmetic treatment, which is normally used to smooth wrinkles, was found to destroy resistant cancer cells in tests on mice.

Professor Bernard Gallez from Louvain University in Brussels injected botulinum neurotoxin type A, otherwise known as Botox, into two types of cancerous tumours in mice.

After injecting the tumours they were then examined for three days.

The team found it could slow the growth of the tumour and hindered the action of the neurotransmitters which the tumours rely on to grow.

Professor Gallez says the treatment could be used as a "pre-treatment" to other conventional cancer treatments.

He said: "Hypoxia is a source of resistance to radiotherapy, and is a determining factor in the poor prognosis of tumours to cytotoxic treatments.

"Botulinum toxin could lead to inhibition of contractions of tumour vessels, improve tumour perfusion and oxygenation, and enhance the response of tumours to radio- and chemotherapy." Since Botox is used in cosmetic procedur...

... All Headline News - Beauty Regimens Fueling Drug Market Economy - February 14, 2006 Content Services Client Login About Contact Jobs Submit News Tip TOP STORIES BUSINESS ENTERTAINMENT HEALTH OFFBEAT POLITICS SPORTS TECHNOLOGY WORLD Beauty Regimens Fueling Drug Market EconomyFebruary 14, 2006 2:00 p.m.

ESTAyinde O.

Chase - All Headline News Staff Writer New York, New York (AHN) - The aging worldwide population combined with rapidly revolutionary lifestyle treatments that revitalize youthfulness and stave off skin damage are the driving forces behind a healthy prescription dermatological drug market, which will see sales of $11.1 billion by 2010.

The data comes courtesy of a new study from market research firm Kalorama Information.

Mary Anne Crandall, RN says, "The aging population is better educated and wants to see results-whether they have wrinkles, skin cancer, or psoriasis.

Today's consumers are savvy to innovative dermatological treatments, derma drug delivery developments, and new prescription drug information which is widely available on the Internet." She continues, "This has changed the face of dermatology as cosmetic dermatology is now in vogue and manufacturers are racing to find new treatments to satiate public demand." With 2005 sales reaching $8.4 billion, The Worldwide Market for Prescription Dermatological Drugs predicts that sales in the antiaging, photodamage, hair treatment, psoriasis, and skin cancer segments will grow further at a rate of 5.7% o...

... PharmaLive: Aging Population Drives Healthy Prescription Dermatological Drug Growth REGISTERED USERS PRODUCT MARKETING NEWS Aging Population Drives Healthy Prescription Dermatological Drug Growth Market Set to Reach $11.1 Billion by 2010 NEW YORK, February 14, 2006 /PRNewswire/ - The aging of the worldwide population and a focus on lifestyle treatments that revitalize youthfulness and stave off skin damage are the driving forces behind a healthy prescription dermatological drug market, which should see sales jump to $11.1 billion by 2010, according to a new study from market research firm Kalorama Information, a division of MarketResearch.com, the leading provider of industry-specific market research reports.

With 2005 sales reaching $8.4 billion, The Worldwide Market for Prescription Dermatological Drugs predicts that sales in the antiaging, photodamage, hair treatment, psoriasis, and skin cancer segments will grow further at a rate of 5.7% over the next four years as consumer demand for newer and better derma drugs continues to increase as the aging population struggles to deal with a myriad of skin disorders and diseases.

While sales of prescription acne, Rosacea, dermatitis, seborrhea, and hyperpigmentation/melasma products have continued to perform well-although with slower growth rates during the last five years as many of these drugs are older or have lost patent protection-the overall market has been bolstered by recent trends in cosmeceuticals, a favorite among...